PharmacoEconomics

, Volume 16, Supplement 1, pp 1–5 | Cite as

Individual and Community Impact of Influenza

Section 1: Assessing The Impact Of Influenza Review Article

Abstract

Influenza has been recognised as a distinct entity for centuries because of its profound effect on respiratory morbidity and mortality, although the full burden of the disease has been difficult to determine. The population groups most affected by influenza morbidity and mortality have also been recognised for years and are strongly related to the viral type or subtype circulating.

Studies in the US suggest that the traditional pneumonia and influenza (P&I) mortality rate underestimates the total impact of influenza onmortality by a factor of approximately 3.8. Observations in different parts of the world confirm that mortality associated with P&I is not limited to specific countries. Vaccination not only reduces the severity of illness and death from P&I, but also reduces all-cause mortality, thus confirming these observations.

Estimates of overall morbidity vary widely, depending on the methods used in various observational studies. The actual impact of influenza is likely to be within this range of estimates, but recent vaccination studies suggest the possibility of much higher rates of morbidity than previously estimated.

Keywords

Influenza Adis International Limited Influenza Vaccine Excess Death Influenza Epidemic 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Francis Jr T. The new acquaintance. Ann Intern Med 1953; 39: 203–21PubMedGoogle Scholar
  2. 2.
    Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998; 47 (RR-6): 1–26Google Scholar
  3. 3.
    Serfling RE, Sherman IL, Housworth WJ. Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics, United States, 1957–58, 1960, and 1963. Am J Epidemiol 1967; 86: 433–41Google Scholar
  4. 4.
    Monto AS. Influenza: quantifying morbidity and mortality. Am J Med 1987; 82 (6A): 20–5PubMedCrossRefGoogle Scholar
  5. 5.
    Sabin AB. Mortality from pneumonia and risk conditions during influenza epidemics. High influenza morbidity during nonepidemic years. JAMA 1977; 237: 2823–8CrossRefGoogle Scholar
  6. 6.
    Baron RC, Dickee RC, Bussel KE, et al. Assessing trends in mortality in 121 US cities, 1970–1979, from all causes and from pneumonia and influenza. Public Health Report 1988; 103: 120–8Google Scholar
  7. 7.
    Serfling RE. Methods for current statistical analysis of excess pneumonia-influenza deaths. Public Health Rep 1963; 78: 494–506PubMedCrossRefGoogle Scholar
  8. 8.
    LuiK-J, Kendal AP. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health 1987; 77: 712–6CrossRefGoogle Scholar
  9. 9.
    Collins SD. Excess mortality from causes other than influenza and pneumonia during influenza epidemics. Public Health Rep 1932; 47: 2159–81CrossRefGoogle Scholar
  10. 10.
    Simonsen L, Clarke MJ, Williamson GD, et al. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997; 87: 1944–50PubMedCrossRefGoogle Scholar
  11. 11.
    Nicholson KG. Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990. Epidemiol Infect 1996; 116: 51–63PubMedCrossRefGoogle Scholar
  12. 12.
    Foster DA, Talsma A, Furumoto-Dawson A, et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992; 136: 296–307PubMedGoogle Scholar
  13. 13.
    Ohmit SE, Monto AS. Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. Int J Epidemiol 1995; 24: 1240–8PubMedCrossRefGoogle Scholar
  14. 14.
    Nichol KL, Margolis KL, Wuorenma J, et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778–806PubMedCrossRefGoogle Scholar
  15. 15.
    Fedson DS, Wajda A, Nicol JP, et al. Clinical effectiveness of influenza vaccination in Manitoba. JAMA 1993; 270: 1956–61PubMedCrossRefGoogle Scholar
  16. 16.
    Monto AS, Koopman JS, Longini Jr IM. Tecumseh study of illness: XII. Influenza infection and disease, 1976–1981. Am J Epidemiol 1985; 121: 811–22 17. Monto AS, Kioumehr F. The Tecumseh study of respiratory illness. IX. Occurrence of influenza in the community, 1966- 1971. Am J Epidemiol 1975; 102: 553–63Google Scholar
  17. 18.
    Sullivan KM, Monto AS, Longini Jr IM. Estimates of the US health impact of influenza. Am J Public Health 1993; 83: 1712–6PubMedCrossRefGoogle Scholar
  18. 19.
    Monto AS, Maassab HF. Ether treatment of type B influenza virus antigen for the hemagglutination inhibition test. J Clin Microbiol 1981; 13: 54–7PubMedGoogle Scholar
  19. 20.
    Glezen WP, Frank AL, Taber LH, et al. Influenza in childhood. Pediatr Res 1984; 17: 1029–32Google Scholar
  20. 21.
    Glezen WP, Six HR, Perrotta DM, et al. Epidemics and their causative viruses – community experience. In: Stuart-Harris C, Potter CW, editors. The molecular virology and epidemiology of influenza. New York: Academic Press, 1984Google Scholar
  21. 22.
    Nichol KL, Lind A, Margolis KL, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995; 333: 889–93PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1999

Authors and Affiliations

  1. 1.School of Public HealthUniversity of MichiganAnn ArborUSA

Personalised recommendations